

Price To Earnings Ratio 47.34 | Sector PE 33.18 |
PB Ratio 11.94 | Sector PB 5.75 |
EPS 63.85 | Dividend Yield 0.97 |
Today's Volume 195.790 K | 5 Day Avg. Volume 102.438 K |
PEG Ratio 1.32 | Market Cap. ₹ 26,230.00 Cr. |


Dr. Lal PathLabs Limited is an Indian company providing diagnostic and related healthcare tests and services. The company's activities include management of biochemistry, haematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology and other pathological and radiological research laboratories. It offers a variety of condition-based tests, including allergies, diabetes, health checks, viral infections, fever, heart disease, hypertension, cancer, miscarriages, anaemia, arthritis, breast cancer, diphtheria, liver disease, bone disease, abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscle disorders and viral infections. The company's subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited and Dr. Lal PathLabs Nepal Private Limited.